Intravacc, Primrose to advance conjugate vaccine development
Contract development and manufacturing organisation (CDMO) Intravacc and biotechnology company Primrose Bio have announced a strategic collaboration aimed at bolstering …
EC approves Merck’s KEYTRUDA regimen for NSCLC treatment
The European Commission (EC) has approved Merck’s KEYTRUDA regimen for treating adult patients with resectable non-small cell lung cancer (NSCLC) …
Pharmaceutical compounding companies in contract manufacturing for the pharmaceutical industry
Pharmaceutical compounding has gained popularity as it helps in preparing personalised medications for patients. The individual ingredients are mixed in …
ReAlta signs deal with NIAID to develop drug for radiation poisoning
US-based pharma company ReAlta Life Sciences has teamed up with the US National Institute of Allergy and Infectious Diseases (NIAID) …
Protein and peptide synthesis and manufacturing solutions for the pharmaceutical industry
The significant rise in the use of biopharmaceutical and large molecule therapeutics over recent years has made peptides and proteins …
Lab equipment suppliers for the pharmaceutical industry
Laboratory equipment, instrumentation and consumables are critical in the research and development of novel medicines and vaccines. Lab equipment suppliers …
Measles cases continue to rise in US amid lagging vaccination rates
According to the latest data from the US Centers for Disease Control and Prevention (CDC), over 64 cases of measles …
Nanoscope Therapeutics exhibits positive top-line Phase IIb results for MCO-010
Nanoscope Therapeutics released promising top-line results for its RESTORE trial, which is studying the gene therapy MCO-010 in patients with …
CRISPR drug licensing deals secure $21bn in top three therapy areas over five years
Licensing agreements for innovator drugs utilising clustered regularly interspaced short palindromic repeats (CRISPR) technologies saw oncology, immunology, and central nervous system …
Xilio and Gilead partner up for IL-12 therapeutic development
Gilead Sciences and Xilio Therapeutics declared an exclusive license agreement for the development of a tumour-activated IL-12 program. Under the deal, …
Cheap drugs, inspections, and a future war in Europe – what’s driving drug shortages?
Drug shortages are worsening globally, leaving patients without access to essential medications, and healthcare providers struggling to find alternative treatments. …
Boundless Bio raises $100m as IPO market rouses
US-based Boundless Bio will offer 6,250,000 shares for $16 each as the oncology company hears the bell on the Nasdaq …
OSE Immunotherapeutics gets grant for anti-human SIRPA antibody for treating cancer
OSE Immunotherapeutics has been granted a patent for antibodies targeting human SIRPa, enhancing antigen presentation to T cells. The invention …
Cidara Therapeutics gets grant for conjugates for treating viral infections
Cidara Therapeutics has been granted a patent for compositions and methods for treating viral infections using conjugates containing neuraminidase inhibitors …
Synlogic gets grant for genetically engineered bacteria for treating phenylketonuria
Synlogic has been granted a patent for genetically programmed microorganisms, like bacteria, for modulating and treating diseases. The patent includes …